ATE497960T1 - A1-adenosinrezeptoragonisten - Google Patents

A1-adenosinrezeptoragonisten

Info

Publication number: ATE497960T1
Authority: AT; Austria
Prior art keywords: receptor agonists; adenosine receptor; angina; release; useful
Prior art date: 2005-10-13

Application number

AT06825861T

Other languages

English (en)

Inventor

Elfatih Elzein

Xiaofen Li

Jeff Zablocki

Original Assignee

Cv Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-13

Filing date

2006-10-11

Publication date

2011-02-15

2006-10-11 Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc

2011-02-15 Application granted granted Critical

2011-02-15 Publication of ATE497960T1 publication Critical patent/ATE497960T1/de

Links

101150007969 ADORA1 gene Proteins 0.000 title abstract 2
239000003379 purinergic P1 receptor agonist Substances 0.000 title abstract 2
201000010099 disease Diseases 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
206010002383 Angina Pectoris Diseases 0.000 abstract 1
206010003662 Atrial flutter Diseases 0.000 abstract 1
208000001871 Tachycardia Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
235000021588 free fatty acids Nutrition 0.000 abstract 1
208000010125 myocardial infarction Diseases 0.000 abstract 1
150000005830 nonesterified fatty acids Chemical class 0.000 abstract 1
230000006794 tachycardia Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Obesity (AREA)
Hematology (AREA)
Genetics & Genomics (AREA)
Child & Adolescent Psychology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

AT06825861T 2005-10-13 2006-10-11 A1-adenosinrezeptoragonisten ATE497960T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72661605P	2005-10-13	2005-10-13
PCT/US2006/039975 WO2007047401A2 (en)	2005-10-13	2006-10-11	A1 adenosine receptor agonists

Publications (1)

Publication Number	Publication Date
ATE497960T1 true ATE497960T1 (de)	2011-02-15

Family

ID=37865975

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06825861T ATE497960T1 (de)	2005-10-13	2006-10-11	A1-adenosinrezeptoragonisten

Country Status (8)

Country	Link
US (2)	US7488720B2 (de)
EP (1)	EP1943251B8 (de)
JP (1)	JP2009511593A (de)
AT (1)	ATE497960T1 (de)
CA (1)	CA2625783A1 (de)
DE (1)	DE602006020057D1 (de)
ES (1)	ES2358351T3 (de)
WO (1)	WO2007047401A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE497960T1 (de) *	2005-10-13	2011-02-15	Cv Therapeutics Inc	A1-adenosinrezeptoragonisten
CN101712709A (zh) *	2008-10-06	2010-05-26	中国医学科学院药物研究所	三乙酰基-3-羟基苯基腺苷及其调血脂的用途
CN110545822A (zh) *	2017-05-19	2019-12-06	全技术公司	药剂、组合物及其相关方法
JP2025520300A (ja) *	2022-06-17	2025-07-03	上海森輝医薬有限公司	シクロペンチルアデノシン誘導体及びその医薬的使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3845770A (en) *	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US4326525A (en) *	1980-10-14	1982-04-27	Alza Corporation	Osmotic device that improves delivery properties of agent in situ
US5364620A (en)	1983-12-22	1994-11-15	Elan Corporation, Plc	Controlled absorption diltiazem formulation for once daily administration
US5023252A (en) *	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
US4992445A (en) *	1987-06-12	1991-02-12	American Cyanamid Co.	Transdermal delivery of pharmaceuticals
US4902514A (en) *	1988-07-21	1990-02-20	Alza Corporation	Dosage form for administering nilvadipine for treating cardiovascular symptoms
DE69932173T2 (de) *	1998-10-16	2007-06-06	Pfizer Inc.	Adeninderivate
US20030013675A1 (en) *	2001-05-25	2003-01-16	Boehringer Ingelheim Pharma Kg	Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
US20030078232A1 (en) *	2001-08-08	2003-04-24	Elfatih Elzein	Adenosine receptor A3 agonists
NZ541651A (en)	2003-02-03	2009-01-31	Cv Therapeutics Inc	Partial and full agonists of A1 adenosine receptors
ATE497960T1 (de) *	2005-10-13	2011-02-15	Cv Therapeutics Inc	A1-adenosinrezeptoragonisten

2006
- 2006-10-11 AT AT06825861T patent/ATE497960T1/de active
- 2006-10-11 DE DE602006020057T patent/DE602006020057D1/de active Active
- 2006-10-11 WO PCT/US2006/039975 patent/WO2007047401A2/en not_active Ceased
- 2006-10-11 US US11/546,658 patent/US7488720B2/en not_active Expired - Fee Related
- 2006-10-11 CA CA002625783A patent/CA2625783A1/en not_active Abandoned
- 2006-10-11 ES ES06825861T patent/ES2358351T3/es active Active
- 2006-10-11 JP JP2008535686A patent/JP2009511593A/ja active Pending
- 2006-10-11 EP EP06825861A patent/EP1943251B8/de active Active
2009
- 2009-02-03 US US12/365,072 patent/US20090137520A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20070087994A1 (en)	2007-04-19
EP1943251B1 (de)	2011-02-09
US20090137520A1 (en)	2009-05-28
WO2007047401A2 (en)	2007-04-26
JP2009511593A (ja)	2009-03-19
WO2007047401A3 (en)	2007-06-14
EP1943251A2 (de)	2008-07-16
CA2625783A1 (en)	2007-04-26
DE602006020057D1 (de)	2011-03-24
ES2358351T3 (es)	2011-05-09
EP1943251B8 (de)	2011-03-23
ES2358351T8 (es)	2011-06-15
US7488720B2 (en)	2009-02-10

Similar Documents

Publication	Publication Date	Title
EA200970519A1 (ru)	2009-12-30	Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
EA200800100A1 (ru)	2008-06-30	Соединения азаиндазола и способы применения
CL2009001476A1 (es)	2010-01-11	Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
NO20081212L (no)	2008-05-06	Xantinderivater som selektive HM74A agonister
EA200800727A1 (ru)	2008-08-29	Введение ингибиторов дипептидилпептидазы
IN2012DN02452A (de)	2015-08-21
ECSP077836A (es)	2008-01-23	Compuestos mejorados farmacocinéticamente
CL2011000978A1 (es)	2011-09-23	Compuestos derivados de fenil-amida o piridil-amida, agonistas de gpbar1; proceso de preparacion; composicion farmaceutica; y su uso en diabetes, isquemia, obesidad, dislipidemia, entre otras.
MA30158B1 (fr)	2009-01-02	Compositions et procedes d'utilisation d'anticorps contre dickkopf-1
EA201071221A1 (ru)	2011-08-30	Гетероциклические соединения
WO2004069185A3 (en)	2004-09-23	Partial and full agonists of a1 adenosine receptors
ES2337973B8 (es)	2011-07-21	Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
ATE497960T1 (de)	2011-02-15	A1-adenosinrezeptoragonisten
TW200616649A (en)	2006-06-01	Partial and full agonists of A1 adenosine receptors
ECSP077845A (es)	2008-02-20	Composiciones y sales dermatológicas para el tratamiento de enfermedades dermatológicas
CL2011001496A1 (es)	2011-10-28	Compuestos derivados de 2-piridin-2-il-pirazol-3(2h)-ona, activadores de hif; composicion farmaceutica que los comprende; procedimiento de preparacion de estos; y su uso en el tratamiento de enfermedades cardiacas perifericas de origen isquemico, entre otras.
EA200701592A1 (ru)	2008-04-28	Композиты и способы их получения и использования
ATE474834T1 (de)	2010-08-15	Als agonisten des gpr38-rezeptors geeignete biarylverbindungen
TW200621793A (en)	2006-07-01	Partial and full agonists of a1 adenosine receptors
CL2007001091A1 (es)	2008-01-04	Compuestos derivados de ciclopropan dicarboxamida, inhibidores del factor de coagulacion xa; composiciones farmaceuticas; y su uso para tratar desordenes tromboticos, trombosis arterial o venosa, trombosis venosa profunda, enfermedad arterial periferica oclusiva y angina pectoris inestable, infarto al miocardio, entre otras.
FR2889976B1 (fr)	2009-05-29	Appaeil de traitement par voie humide.
WO2006116197A3 (en)	2009-05-14	Methods of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding
TH83828B (th)	2007-04-05	ชิ้นส่วนรองเท้า
BRPI0602614A (pt)	2006-12-26	utilização de amido desramificado na extrusão - esferonização de pelotas farmacêuticas
GB2458016A (en)	2009-09-09	Protein probe compounds, compositions, and methods

Legal Events

Date

Code

Title

Description

2011-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1943251

Country of ref document: EP